These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38342578)

  • 1. Management of tinea capitis in infants and children in the United States: A national survey of pediatric dermatologists.
    Guo L; Tran J; Sun DI; Newton JS; D'Amiano NM; Lai J; Cohen B
    Pediatr Dermatol; 2024; 41(2):263-265. PubMed ID: 38342578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinea capitis update: a continuing conflict with an old adversary.
    Chen BK; Friedlander SF
    Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment and management of tinea capitis in children.
    Ali S; Graham TA; Forgie SE
    Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tinea capitis.
    Alvarez MS; Silverberg NB
    Cutis; 2006 Sep; 78(3):189-96. PubMed ID: 17036663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers.
    Woodard AA; Le TK; DiBiagio JR; Goldenberg NA; Cohen BA
    J Pediatr; 2021 Jul; 234():269-272. PubMed ID: 33794219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the management of tinea capitis in children.
    Kakourou T; Uksal U;
    Pediatr Dermatol; 2010; 27(3):226-8. PubMed ID: 20609140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
    Gold JAW; Benedict K; Dulski TM; Lipner SR
    J Am Acad Dermatol; 2023 Jul; 89(1):133-135. PubMed ID: 36806646
    [No Abstract]   [Full Text] [Related]  

  • 14. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinea capitis: a treatment update.
    Roberts BJ; Friedlander SF
    Pediatr Ann; 2005 Mar; 34(3):191-200. PubMed ID: 15792111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of tinea capitis in Israel: A comparative study.
    Shemer A; Gupta AK; Galili E; Daniel R; Kassem R; Farhi R; Grunwald H; Bamimore MA
    Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinea capitis: an overview with emphasis on management.
    Gupta AK; Hofstader SL; Adam P; Summerbell RC
    Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tinea capitis: advances and a needed paradigm shift.
    Le TK; Cohen BA
    Curr Opin Pediatr; 2021 Aug; 33(4):387-391. PubMed ID: 34226424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
    Bennett ML; Fleischer AB; Loveless JW; Feldman SR
    Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.